173 related articles for article (PubMed ID: 18337551)
1. Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
Urquhart BL; Freeman DJ; Cutler MJ; Mainra R; Spence JD; House AA
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1041-7. PubMed ID: 18337551
[TBL] [Abstract][Full Text] [Related]
2. Mesna for the treatment of hyperhomocysteinemia in hemodialysis patients.
Cutler MJ; Urquhart BL; Freeman DJ; Spence JD; House AA
Blood Purif; 2009; 27(3):306-10. PubMed ID: 19270449
[TBL] [Abstract][Full Text] [Related]
3. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
House AA; Eliasziw M; Urquhart BL; Freeman DJ; Spence JD
Am J Kidney Dis; 2004 Oct; 44(4):689-94. PubMed ID: 15384020
[TBL] [Abstract][Full Text] [Related]
4. The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.
Urquhart BL; Freeman DJ; Spence JD; House AA
Am J Kidney Dis; 2007 Jan; 49(1):109-17. PubMed ID: 17185151
[TBL] [Abstract][Full Text] [Related]
5. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
7. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study.
Sunder-Plassmann G; Födinger M; Buchmayer H; Papagiannopoulos M; Wojcik J; Kletzmayr J; Enzenberger B; Janata O; Winkelmayer WC; Paul G; Auinger M; Barnas U; Hörl WH
J Am Soc Nephrol; 2000 Jun; 11(6):1106-1116. PubMed ID: 10820175
[TBL] [Abstract][Full Text] [Related]
8. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
[TBL] [Abstract][Full Text] [Related]
9. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
[TBL] [Abstract][Full Text] [Related]
10. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.
Ossareh S; Shayan-Moghaddam H; Salimi A; Asgari M; Farrokhi F
Iran J Kidney Dis; 2009 Oct; 3(4):227-33. PubMed ID: 19841527
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study.
Saifan C; El-Charabaty E; El-Sayegh S
Vasc Health Risk Manag; 2013; 9():361-4. PubMed ID: 23898227
[TBL] [Abstract][Full Text] [Related]
12. Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.
Polkinghorne KR; Zoungas S; Branley P; Villanueva E; McNeil JJ; Atkins RC; McGrath BP; Kerr PG
Intern Med J; 2003 Nov; 33(11):489-94. PubMed ID: 14656250
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
14. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
Thambyrajah J; Landray MJ; McGlynn FJ; Jones HJ; Wheeler DC; Townend JN
Circulation; 2000 Aug; 102(8):871-5. PubMed ID: 10952955
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
[TBL] [Abstract][Full Text] [Related]
16. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.
Tungkasereerak P; Ong-ajyooth L; Chaiyasoot W; Ong-ajyooth S; Leowattana W; Vasuvattakul S; Vareesangthip K; Shayakul C; Chanchairujira T; Sritippayawan S
J Med Assoc Thai; 2006 Aug; 89(8):1187-93. PubMed ID: 17048428
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
Hong SY; Yang DH; Chang SK
Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
[TBL] [Abstract][Full Text] [Related]
18. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
19. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
20. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
Bostom AG; Shemin D; Bagley P; Massy ZA; Zanabli A; Christopher K; Spiegel P; Jacques PF; Dworkin L; Selhub J
Circulation; 2000 Jun; 101(24):2829-32. PubMed ID: 10859289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
